194 related articles for article (PubMed ID: 24089061)
1. Benign adrenal hemangiomas may mimic metastases on PET.
Calata JF; Sukerkar AN; August CZ; Maker AV
Clin Nucl Med; 2013 Nov; 38(11):888-90. PubMed ID: 24089061
[TBL] [Abstract][Full Text] [Related]
2. [Cavernous hemangioma: rare incidentaloma of the adrenal gland].
de la Villéon B; Goudard Y; Peroux E; Jacquet SF; Aubert P; Duverger V
Prog Urol; 2011 Dec; 21(13):961-4. PubMed ID: 22118362
[TBL] [Abstract][Full Text] [Related]
3. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
Ozcan Kara P; Kara T; Kara Gedik G; Kara F; Sahin O; Ceylan Gunay E; Sari O
Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
[TBL] [Abstract][Full Text] [Related]
4. Adrenal Hemangioma Definite Diagnosis on CT, MRI, and FDG PET in a Patient With Primary Lung Cancer.
Wilson B; Becker A; Estes T; Keshavamurthy J; Pucar D
Clin Nucl Med; 2018 Jun; 43(6):e192-e194. PubMed ID: 29561525
[TBL] [Abstract][Full Text] [Related]
5. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
[TBL] [Abstract][Full Text] [Related]
6. PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients.
Boland GW; Blake MA; Holalkere NS; Hahn PF
AJR Am J Roentgenol; 2009 Apr; 192(4):956-62. PubMed ID: 19304700
[TBL] [Abstract][Full Text] [Related]
7. Does 18F-FDG PET/MRI reduce the number of indeterminate abdominal incidentalomas compared with 18F-FDG PET/CT?
Schaarschmidt BM; Grueneisen J; Heusch P; Gomez B; Umutlu L; Ruhlmann V; Rosenbaum-Krumme S; Antoch G; Buchbender C
Nucl Med Commun; 2015 Jun; 36(6):588-95. PubMed ID: 25759944
[TBL] [Abstract][Full Text] [Related]
8. Radiologic evaluation of incidentally discovered adrenal masses.
Willatt JM; Francis IR
Am Fam Physician; 2010 Jun; 81(11):1361-6. PubMed ID: 20521756
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer.
Kumar R; Xiu Y; Yu JQ; Takalkar A; El-Haddad G; Potenta S; Kung J; Zhuang H; Alavi A
J Nucl Med; 2004 Dec; 45(12):2058-62. PubMed ID: 15585482
[TBL] [Abstract][Full Text] [Related]
10. Utility of PET/CT in differentiating benign from malignant adrenal nodules in patients with cancer.
Vikram R; Yeung HD; Macapinlac HA; Iyer RB
AJR Am J Roentgenol; 2008 Nov; 191(5):1545-51. PubMed ID: 18941099
[TBL] [Abstract][Full Text] [Related]
11. F-18 FDG PET/CT demonstration of an adrenal metastasis in a patient with anaplastic thyroid cancer.
Iagaru A; McDougall IR
Clin Nucl Med; 2007 Jan; 32(1):13-5. PubMed ID: 17179796
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of incidentally discovered adrenal masses with PET and PET/CT.
Wong KK; Arabi M; Bou-Assaly W; Marzola MC; Rubello D; Gross MD
Eur J Radiol; 2012 Mar; 81(3):441-50. PubMed ID: 21295930
[TBL] [Abstract][Full Text] [Related]
13. Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions.
Maurea S; Mainolfi C; Bazzicalupo L; Panico MR; Imparato C; Alfano B; Ziviello M; Salvatore M
AJR Am J Roentgenol; 1999 Jul; 173(1):25-9. PubMed ID: 10397094
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI.
Yun M; Kim W; Alnafisi N; Lacorte L; Jang S; Alavi A
J Nucl Med; 2001 Dec; 42(12):1795-9. PubMed ID: 11752075
[TBL] [Abstract][Full Text] [Related]
15. FDG PET/CT in detection of adrenal metastasis in patients with renal cell carcinoma.
Kumar R; Shamim SA; Shandal V; Sharma P; Gadodia A; Malhotra A
Clin Nucl Med; 2011 Jul; 36(7):513-7. PubMed ID: 21637050
[TBL] [Abstract][Full Text] [Related]
16. Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy--initial experience.
Blake MA; Slattery JM; Kalra MK; Halpern EF; Fischman AJ; Mueller PR; Boland GW
Radiology; 2006 Mar; 238(3):970-7. PubMed ID: 16505394
[TBL] [Abstract][Full Text] [Related]
17. [Positron emission tomography (PET) with fludeoxyglucose F 18 in the study of adrenal masses: comparison of benign and malignant lesions].
Maurea S; Mainolfi C; Wang H; Varrella P; Panico MR; Klain M; Rossi R; Cremona F; Bazzicalupo L; Salvatore M
Radiol Med; 1996 Dec; 92(6):782-7. PubMed ID: 9122472
[TBL] [Abstract][Full Text] [Related]
18. Importance of adrenal incidentaloma in patients with a history of malignancy.
Frilling A; Tecklenborg K; Weber F; Kühl H; Müller S; Stamatis G; Broelsch C
Surgery; 2004 Dec; 136(6):1289-96. PubMed ID: 15657589
[TBL] [Abstract][Full Text] [Related]
19. Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results.
Naswa N; Sharma P; Soundararajan R; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
Diagn Interv Radiol; 2013; 19(4):294-8. PubMed ID: 23439252
[TBL] [Abstract][Full Text] [Related]
20. Adrenal masses of varied etiology: anatomical and molecular imaging features on PET-CT.
Sharma P; Singh H; Dhull VS; Suman KC S; Kumar A; Bal C; Kumar R
Clin Nucl Med; 2014 Mar; 39(3):251-60. PubMed ID: 24217551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]